310 related articles for article (PubMed ID: 2141665)
1. Fluorescent and biotin probes for dopamine receptors: D1 and D2 receptor affinity and selectivity.
Madras BK; Canfield DR; Pfaelzer C; Vittimberga FJ; Difiglia M; Aronin N; Bakthavachalam V; Baindur N; Neumeyer JL
Mol Pharmacol; 1990 Jun; 37(6):833-9. PubMed ID: 2141665
[TBL] [Abstract][Full Text] [Related]
2. Fluorescent probes for dopamine receptors: synthesis and characterization of fluorescein and 7-nitrobenz-2-oxa-1,3-diazol-4-yl conjugates of D-1 and D-2 receptor ligands.
Bakthavachalam V; Baindur N; Madras BK; Neumeyer JL
J Med Chem; 1991 Nov; 34(11):3235-41. PubMed ID: 1956042
[TBL] [Abstract][Full Text] [Related]
3. Multiple fluorescent ligands for dopamine receptors. II. Visualization in neural tissues.
Ariano MA; Kang HC; Haugland RP; Sibley DR
Brain Res; 1991 May; 547(2):208-22. PubMed ID: 1884196
[TBL] [Abstract][Full Text] [Related]
4. Multiple fluorescent ligands for dopamine receptors. I. Pharmacological characterization and receptor selectivity.
Barton AC; Kang HC; Rinaudo MS; Monsma FJ; Stewart-Fram RM; Macinko JA; Haugland RP; Ariano MA; Sibley DR
Brain Res; 1991 May; 547(2):199-207. PubMed ID: 1679366
[TBL] [Abstract][Full Text] [Related]
5. Characterization of novel fluorescent ligands with high affinity for D1 and D2 dopaminergic receptors.
Monsma FJ; Barton AC; Kang HC; Brassard DL; Haugland RP; Sibley DR
J Neurochem; 1989 May; 52(5):1641-4. PubMed ID: 2523470
[TBL] [Abstract][Full Text] [Related]
6. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
8. D1 and D2 dopamine receptors in caudate-putamen of nonhuman primates (Macaca fascicularis).
Madras BK; Fahey MA; Canfield DR; Spealman RD
J Neurochem; 1988 Sep; 51(3):934-43. PubMed ID: 2970527
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
Santanavanich C; Ebadi M; Govitrapong P
J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338
[TBL] [Abstract][Full Text] [Related]
10. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
11. Direct visualization and cellular localization of D1 and D2 dopamine receptors in rat forebrain by use of fluorescent ligands.
Ariano MA; Monsma FJ; Barton AC; Kang HC; Haugland RP; Sibley DR
Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8570-4. PubMed ID: 2479025
[TBL] [Abstract][Full Text] [Related]
12. Stereoisomeric probes for the D1 dopamine receptor: synthesis and characterization of R-(+) and S-(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its 6-bromo analogue.
Neumeyer JL; Kula NS; Baldessarini RJ; Baindur N
J Med Chem; 1992 Apr; 35(8):1466-71. PubMed ID: 1533424
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of the D1- and D2-like dopamine receptors from the brain of the leopard frog, Rana pipiens.
Chu J; Wilczynski W; Wilcox RE
Brain Behav Evol; 2001 Jun; 57(6):328-42. PubMed ID: 11713387
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
Enjalbert A; Bockaert J
Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
[TBL] [Abstract][Full Text] [Related]
15. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
Roseboom PH; Gnegy ME
Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
[TBL] [Abstract][Full Text] [Related]
16. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G
Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
[TBL] [Abstract][Full Text] [Related]
17. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
Pugsley TA; Davis MD; Akunne HC; MacKenzie RG; Shih YH; Damsma G; Wikstrom H; Whetzel SZ; Georgic LM; Cooke LW
J Pharmacol Exp Ther; 1995 Dec; 275(3):1355-66. PubMed ID: 8531103
[TBL] [Abstract][Full Text] [Related]
18. Differential localization of dopamine D1 and D2 receptors in rat retina.
Tran VT; Dickman M
Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1620-6. PubMed ID: 1532792
[TBL] [Abstract][Full Text] [Related]
19. N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain.
Xu SX; Hatada Y; Black LE; Creese I; Sibley DR
J Pharmacol Exp Ther; 1991 May; 257(2):608-15. PubMed ID: 1674530
[TBL] [Abstract][Full Text] [Related]
20. Cellular distribution of dopamine D1 and D2 receptors in rat medial prefrontal cortex.
Vincent SL; Khan Y; Benes FM
J Neurosci; 1993 Jun; 13(6):2551-64. PubMed ID: 8501521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
